Evidence map›Paper›PMID 40729447›Full record

ArticlePsycho-oncology2025

School Bullying of Childhood Leukemia Survivors.

Yaacov B Yablon, Sigal Eden, Michal Dayan-Sharabi, Yifat Ezer-Cohen, Dina Mazor-Yehezkel, Moria Charka, Sigal Dahan, Gali Avrahami, Shlomit Barzilai-Birenboim, Gil Gilad and 6 more

Abstract read
In one paragraph

Article in Psycho-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yaacov B YablonFaculty of Education, Bar-Ilan University, Ramat Gan, Israel.ORCID 0000-0003-2920-9505
Sigal EdenFaculty of Education, Bar-Ilan University, Ramat Gan, Israel.ORCID 0000-0003-4894-461X
Michal Dayan-SharabiDivision of Pediatric Hematology and Oncology, Psychosocial Service, Schneider Children's Medical Center, Petah Tikva, Israel.
Yifat Ezer-CohenDivision of Pediatric Hematology and Oncology, Psychosocial Service, Schneider Children's Medical Center, Petah Tikva, Israel.
Dina Mazor-YehezkelDivision of Pediatric Hematology and Oncology, Psychosocial Service, Schneider Children's Medical Center, Petah Tikva, Israel.
Moria CharkaDivision of Pediatric Hematology and Oncology, Education Center, Schneider Children's Medical Center, Petah Tikva, Israel.
Sigal DahanDivision of Pediatric Hematology and Oncology, Education Center, Schneider Children's Medical Center, Petah Tikva, Israel.
Gali AvrahamiDivision of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
Shlomit Barzilai-BirenboimDivision of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.ORCID 0000-0002-3994-0556
Gil GiladDivision of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
Liron MartinDivision of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
Irit Schwartz-AttiasMeir Academic Nursing School, Meir Medical Center, Kfar Saba, Israel.
Anat YahelDivision of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
Shai IzraeliDivision of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
Naomi LiticheverDivision of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
Sarah ElitzurDivision of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.

Funding

Davidoff FoundationIsrael Cancer Association 20130022
6 · The paper itself

Abstract

backgroundWith improving childhood cancer cure rates, there is a growing focus on the long-term health and well-being of survivors. School reintegration is crucial for their rehabilitation and psychosocial adaptation, yet little is known about school violence and bullying faced by cancer survivors upon their return.

aimsThis study aimed to investigate the prevalence and forms of school bullying against childhood acute lymphoblastic leukemia (ALL) survivors, identifying risk and protective factors.

methodsALL survivors aged 6-18 years were assessed through interviews and questionnaires. A paired comparison group of healthy students was recruited from their classrooms.

resultsThe study included 70 students from grades 6-12 (mean age 14.9 ± 1.82 years), comprising 35 ALL survivors and a paired comparison group. ALL survivors endured more physical (M = 1.64, SD = 1.00) and relational bullying (M = 1.50, SD = 1.04) than their healthy classmates (M = 0.90, SD = 0.58; M = 0.90, SD = 0.51 respectively), while facing similar verbal bullying levels (M = 1.71, SD = 0.99 vs. M = 1.38, SD = 0.69). However, survivors reported less cyberbullying (M = 0.45, SD = 0.36) and severe bullying (M = 0.41, SD = 0.05) than their healthy classmates (M = 1.49, SD = 0.48; M = 0.66, SD = 0.53 respectively). Survivors who returned to a different school cohort post-remission faced higher bullying risks than those who rejoined their original cohort (-0.79 < β < -0.92; p < 0.001). Physical disfigurements following cancer treatment were a risk factor for victimization only among those who returned to their original cohort.

conclusionsThe findings highlight the unique challenges faced by childhood leukemia survivors in school reintegration after cancer therapy, emphasizing the significant effect of the school cohort environment on their bullying experiences.

Indexed as

BullyingCancer SurvivorsPrecursor Cell Lymphoblastic Leukemia-LymphomaSchoolsStudentsSurvivorsAdolescentCase-Control StudiesChildCyberbullyingFemaleHumansMalePrevalenceRisk FactorsSurveys and Questionnairesbullyingcancercancer survivorshipchildrenleukemiaoncologyschool

Identifiers

PMID40729447
PMCPMC12306848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.